12 research outputs found
Supplementary Table S4 from Collagen-Anchored Interleukin-2 and Interleukin-12 Safely Reprogram the Tumor Microenvironment in Canine Soft-Tissue Sarcomas
Soft tissue sarcoma subtype classifications</p
Supplementary Figure S3 from Collagen-Anchored Interleukin-2 and Interleukin-12 Safely Reprogram the Tumor Microenvironment in Canine Soft-Tissue Sarcomas
IFN-γ and IL-10 individual replicates from Milliplex, healthy beagles</p
Supplementary Figure S6 from Collagen-Anchored Interleukin-2 and Interleukin-12 Safely Reprogram the Tumor Microenvironment in Canine Soft-Tissue Sarcomas
Pathway scores from canine Nanostring nSolver analysis</p
Supplementary Table S3 from Collagen-Anchored Interleukin-2 and Interleukin-12 Safely Reprogram the Tumor Microenvironment in Canine Soft-Tissue Sarcomas
Soft tissue sarcoma canine patient information</p
Supplementary Figure S2 from Collagen-Anchored Interleukin-2 and Interleukin-12 Safely Reprogram the Tumor Microenvironment in Canine Soft-Tissue Sarcomas
Collagen-binding ELISA comparison to prior mouse constructs</p
Supplementary Figure S7 from Collagen-Anchored Interleukin-2 and Interleukin-12 Safely Reprogram the Tumor Microenvironment in Canine Soft-Tissue Sarcomas
Pathway scores from mouse Nanostring nSolver analysis</p
Supplementary Figure S5 from Collagen-Anchored Interleukin-2 and Interleukin-12 Safely Reprogram the Tumor Microenvironment in Canine Soft-Tissue Sarcomas
PAX5 immunohistochemistry</p
Supplementary Figure S1 from Collagen-Anchored Interleukin-2 and Interleukin-12 Safely Reprogram the Tumor Microenvironment in Canine Soft-Tissue Sarcomas
Patient tumor images and cohorts</p
Supplementary Figure S4 from Collagen-Anchored Interleukin-2 and Interleukin-12 Safely Reprogram the Tumor Microenvironment in Canine Soft-Tissue Sarcomas
IFN-γ and IL-10 individual replicates from Milliplex, sarcoma patients</p
Supplementary Table S2 from Collagen-Anchored Interleukin-2 and Interleukin-12 Safely Reprogram the Tumor Microenvironment in Canine Soft-Tissue Sarcomas
Allometric scaling of IL-2 and IL-12 doses for canine dosing</p